title: On the contribution of group III and IV muscle afferents to the circulatory response to rhythmic exercise in humans.
abstract: We investigated the role of skeletal muscle afferent feedback in circulatory control during rhythmic exercise in humans. Nine healthy males performed single leg knee-extensor exercise (15/30/45 watts, 3 min each) under both control conditions (Ctrl) and with lumbar intrathecal fentanyl impairing μ-opioid receptor-sensitive muscle afferents. Cardiac output and femoral blood flow were determined, and femoral arterial/venous blood samples were collected during the final minute of each workload. To rule out cephalad migration of fentanyl to the brainstem,we documented unchanged resting ventilatory responses to different levels of hypercapnia. There were no haemodynamic differences between conditions at rest. However, during exercise cardiac output was -2 % lower with fentanyl blockade compared to control (P < 0.05), secondary to a 6% and 13% reduction in heart rate and stroke volume, respectively. Throughout exercise mean arterial pressure (MAP) was reduced by 7% (P < 0.01) which is likely to have contributed to the 15% fall in femoral blood flow. However, MAP was not completely responsible for this peripheral haemodynamic change as vascular conductance was also attenuated (-9%). Evidence of increasing noradrenaline spillover (P = 0.09) implicated an elevation in sympathetic outflow in this response. The attenuated femoral blood flow during exercise with fentanyl was associated with a 17%reduction in leg O2 delivery (P < 0.01) and a concomitant rise in the arteriovenous O2 difference (4–9%), but leg O2 consumption remained 7–13% lower than control (P < 0.05). Our findings reveal an essential contribution of continuous muscle afferent feedback to ensure the appropriate haemodynamic and ultimately metabolic response to rhythmic exercise in humans
authors.affiliation: Department of Medicine, University of Utah, Salt Lake City, UT, USA.markus.amann@hsc.utah.edu
authors.forename: Markus
authors.initials: M
authors.lastname: Amann
authors.forename: Sean
authors.initials: S
authors.lastname: Runnels
authors.forename: David E
authors.initials: DE
authors.lastname: Morgan
authors.forename: Joel D
authors.initials: JD
authors.lastname: Trinity
authors.forename: Anette S
authors.initials: AS
authors.lastname: Fjeldstad
authors.forename: D Walter
authors.initials: DW
authors.lastname: Wray
authors.forename: Van R
authors.initials: VR
authors.lastname: Reese
authors.forename: Russell S
authors.initials: RS
authors.lastname: Richardson
mesh_terms: D000328:Adult; D001794:Blood Pressure / Q000502:physiology; D002245:Carbon Dioxide / Q000008:administration & dosage; D002302:Cardiac Output / Q000502:physiology; D015444:Exercise / Q000502:physiology*; D005246:Feedback; D005283:Fentanyl / Q000494:pharmacology; D006339:Heart Rate / Q000502:physiology; D006439:Hemodynamics / Q000502:physiology; D006801:Humans; D006935:Hypercapnia / Q000503:physiopathology; D007866:Leg / Q000098:blood supply; D008297:Male; D018482:Muscle, Skeletal / Q000098:blood supply* / Q000187:drug effects / Q000294:innervation* / Q000378:metabolism; D009475:Neurons, Afferent / Q000502:physiology*; D009638:Norepinephrine / Q000097:blood / Q000378:metabolism; D010101:Oxygen Consumption / Q000502:physiology; D012039:Regional Blood Flow / Q000187:drug effects / Q000502:physiology*; D012146:Rest / Q000502:physiology; D013318:Stroke Volume / Q000502:physiology
chemical_list: D002245:Carbon Dioxide; D005283:Fentanyl; D009638:Norepinephrine